Ionis Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

81.6 3.04

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

78.7

Максимум

81.95

Ключови измерители

By Trading Economics

Приходи

136M

-93M

Продажби

43M

246M

EPS

-0.3

Марж на печалбата

-37.599

Служители

1,402

EBITDA

-4.7B

-69M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+32.1% upside

Дивиденти

By Acuity

Следващи печалби

29.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.7B

14B

Предишно отваряне

78.56

Предишно затваряне

81.6

Настроения в новините

By Acuity

50%

50%

140 / 342 Класиране в Healthcare

Ionis Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.07.2026 г., 23:52 ч. UTC

News
Correlated Moves
Social Media

Meta Platforms Inc. shares fell in after-market trading amid a broader tech market downturn, despite earlier gains on plans for a cloud computing business.

1.07.2026 г., 23:51 ч. UTC

Social Media
News
Correlated Moves
ETF Constituents

Invesco QQQ Trust trading lower after Nasdaq 100 decline, reflecting a market shift away from technology stocks. Notable trades occurred at $737.25.

1.07.2026 г., 23:36 ч. UTC

Correlated Moves
News

Ethereum is trading higher, buoyed by Bitcoin's recent gains. Earlier in the session, Ethereum peaked before pulling back slightly but has since regained ground.

1.07.2026 г., 23:36 ч. UTC

News
Social Media

AMD shares are higher in after-market hours following a $36 million equity award announcement for CEO Lisa T. Su and positive discussions at HPE Discover 2026.

1.07.2026 г., 23:36 ч. UTC

News
Correlated Moves

Ethereum is trading higher, supported by Bitcoin's recent strong move. It pulled back slightly from earlier session highs but remains above Tuesday's close.

1.07.2026 г., 23:31 ч. UTC

News

United States Oil Fund LP advances in after-market trading, despite lower oil prices and mixed global equity performance. No specific news identified for the move.

1.07.2026 г., 23:16 ч. UTC

Correlated Moves
News

Qualcomm Inc. shares rose in after-market trading, reflecting a modest gain since Wednesday's close, amid KLA Corp's price increase and recent index removals.

1.07.2026 г., 23:06 ч. UTC

News
ETF Constituents

Vanguard Growth ETF declines in after-market trading, reversing earlier gains. Broader market faces pressure from economic data and geopolitical tensions.

1.07.2026 г., 23:06 ч. UTC

Social Media
News
ETF Constituents

The SPDR Dow Jones Industrial Average ETF Trust declined slightly in after-market hours, reflecting broader market trends and mixed investor sentiment.

1.07.2026 г., 23:06 ч. UTC

News
Correlated Moves
ETF Constituents

The Nasdaq 100 Index shows slight gains in after-market hours, while the Vanguard Information Technology ETF remains roughly flat amid stable trading conditions.

1.07.2026 г., 22:51 ч. UTC

News

Buy rating upgrade from Guggenheim boosts CHKP in after-market.

1.07.2026 г., 20:07 ч. UTC

News
Social Media

American Airlines shares rise as Bernstein raises price target to $23. FAA's approval for supersonic flights may boost investor sentiment.

1.07.2026 г., 20:07 ч. UTC

News

The Nikkei 225 Index is lower in after-market hours, reflecting significant volatility amid broader market sell-offs in technology stocks. No specific news was identified.

1.07.2026 г., 20:05 ч. UTC

Correlated Moves
ETF Constituents
News

The iShares MSCI United Kingdom ETF is lower today amid reduced Bank of England rate hike expectations and a decline in the U.K. Manufacturing PMI.

1.07.2026 г., 20:04 ч. UTC

Macro News
Macro Event
ETF Constituents
News

The Communication Services Select Sector SPDR Fund is rising amid a broader market rally, driven by strong gains in Meta Platforms and the overall sector.

1.07.2026 г., 20:04 ч. UTC

Social Media
News
Macro Event
ETF Constituents

VanEck Gold Miners ETF declines as broader market dynamics weigh on investor sentiment, despite a rise in spot gold prices to $4,085 an ounce.

1.07.2026 г., 20:04 ч. UTC

Social Media
News
ETF Constituents

iShares China Large-Cap ETF gains amid positive sentiment following the China foreign minister's remarks on U.S. relations and strong performance from constituent stocks.

1.07.2026 г., 20:04 ч. UTC

Correlated Moves
News
Event
Macro Event
Social Media

iShares 20+ Year Treasury Bond ETF declines amid rising Treasury yields and comments from Federal Reserve Chair Kevin Warsh on high prices. The ETF went ex-dividend today at $0.31803.

1.07.2026 г., 20:03 ч. UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

1.07.2026 г., 20:03 ч. UTC

Macro Event
News

Willis Towers Watson PLC launched its expanded CyMax Facility for cyber insurance aimed at SMEs in the EMEA region, boosting shares during Wednesday's session.

1.07.2026 г., 20:03 ч. UTC

News
Correlated Moves

NXP Semiconductors NV's stock is lower amid negative assessment from StockStory, citing revenue concerns and lagging growth compared to industry averages.

1.07.2026 г., 20:03 ч. UTC

Social Media
News

Adobe Inc. is trading higher during Wednesday's session, with analysts suggesting potential for recovery amid ongoing interest in the software sector despite recent challenges.

1.07.2026 г., 20:03 ч. UTC

Social Media
News

Microsoft's stock rises on a five-year partnership with Haleon to enhance AI capabilities. A Jefferies survey shows Azure gaining traction over AWS.

1.07.2026 г., 20:02 ч. UTC

News

Align Technology Inc. shares are higher as the company addresses an antitrust investigation and announces plans for its second-quarter 2026 financial results.

1.07.2026 г., 20:02 ч. UTC

Macro Event
Social Media
News

Automatic Data Processing's stock rose following the ADP National Employment Report, which showed a 98,000 increase in private sector jobs for June.

1.07.2026 г., 20:02 ч. UTC

Correlated Moves
News

Analog Devices Inc. shares are lower today, impacted by a significant decline in the semiconductor sub-sector and broader market volatility.

1.07.2026 г., 19:56 ч. UTC

Correlated Moves
News

The U.S. dollar is near two-week lows, impacting the Invesco Currencyshares Japanese Yen Trust, which is trading roughly flat amid ongoing geopolitical tensions.

1.07.2026 г., 19:56 ч. UTC

Macro Event
Correlated Moves
ETF Constituents
Macro News
News

Energy Select Sector SPDR Fund declines amid broader energy sector downturn and falling crude oil prices. ExxonMobil and Schlumberger contribute to negative performance.

1.07.2026 г., 19:51 ч. UTC

Social Media
News
Macro Event

Cognizant Technology Solutions shares rise following the launch of Cognizant Neuro AI Trust, despite HSBC lowering its price target to $68 from $80.

1.07.2026 г., 19:47 ч. UTC

Correlated Moves
Social Media
News

Alphabet Inc shares are higher as the company surpasses its $1 billion investment target in Africa, despite mixed social media sentiment regarding recent legal challenges.

Сравнение с други в отрасъла

Ценова промяна

Ionis Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

32.1% нагоре

12-месечна прогноза

Среден 104.61 USD  32.1%

Висок 130 USD

Нисък 75 USD

Според 19 анализатори от Wall Street, предложили 12-месечна ценова цел за Ionis Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

19 ratings

17

Купи

2

Задържане

0

Продай

Настроение

By Acuity

140 / 342 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.
help-icon Live chat